Chemical proteomic strategies for the discovery and development of anticancer drugs

Area of Science:

• Biochemistry
• Proteomics
• Pharmacology

Background:

• Cancer remains a leading global cause of death, driving urgent needs for effective drug discovery and development.
• Identifying and validating protein targets and their pathways is a significant challenge in anticancer drug R&D.
• Traditional drug discovery often focuses on proteins, but understanding drug-target interactions is crucial.

Purpose of the Study:

• To provide an updated overview of chemical proteomic strategies for anticancer drug discovery.
• To highlight recent successful applications of these techniques in cancer research.
• To discuss future perspectives, particularly concerning natural products.

Main Methods:

• Utilizing chemical proteomic strategies, combining targeted affinity chromatography with high-throughput mass spectrometry (MS).
• Focusing on methods like activity-based protein profiling (ABPP) and compound-centric chemical proteomics (CCCP).
• Employing targeted affinity chromatographic approaches for drug-target identification.

Main Results:

• Chemical proteomics enables large-scale identification of proteome-wide drug-protein interactions.
• These strategies are powerful tools for elucidating complex mechanisms of anticancer drug action.
• Recent successful applications demonstrate the efficacy of these methods in drug discovery.

Conclusions:

• Chemical proteomic strategies offer a promising avenue for modern anticancer drug discovery and development.
• These techniques facilitate the identification of novel drug targets and pathways.
• Future research should emphasize small molecule natural products and their derivatives within these proteomic frameworks.